Literature DB >> 9844592

Molecular pathology of malignant melanoma.

A Slominski1, J Wortsman, B Nickoloff, K McClatchey, M C Mihm, J S Ross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9844592     DOI： 10.1093/ajcp/110.6.788

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  6 in total

1.  Amelanotic Uveal Melanomas Evaluated by Indirect Ophthalmoscopy Reveal Better Long-Term Prognosis Than Pigmented Primary Tumours-A Single Centre Experience.

Authors:  Anna Markiewicz; Piotr Donizy; Monika Nowak; Mateusz Krzyziński; Martyna Elas; Przemysław M Płonka; Jolanta Orłowska-Heitzmann; Przemysław Biecek; Mai P Hoang; Bożena Romanowska-Dixon
Journal:  Cancers (Basel)       Date:  2022-06-01       Impact factor: 6.575

Review 2.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 3.  Relevance of Vitamin D in Melanoma Development, Progression and Therapy.

Authors:  Anna A Brożyna; Robert M Hoffman; Andrzej T Slominski
Journal:  Anticancer Res       Date:  2020-01       Impact factor: 2.480

4.  Evaluation of melanogenesis in A-375 cells in the presence of DMSO and analysis of pyrolytic profile of isolated melanin.

Authors:  Ewa Chodurek; Arkadiusz Orchel; Joanna Orchel; Sławomir Kurkiewicz; Natalia Gawlik; Zofia Dzierżewicz; Krystyna Stępień
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.

Authors:  J M Karjalainen; J K Kellokoski; A J Mannermaa; H E Kujala; K I Moisio; P J Mitchell; M J Eskelinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 6.  BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.

Authors:  Ningning Yan; Sanxing Guo; Huixian Zhang; Ziheng Zhang; Shujing Shen; Xingya Li
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.